Cargando…

Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids

Multidrug resistance (MDR) resulting from different defensive mechanisms in cancer is one of the major obstacles of clinical treatment. To circumvent MDR many reversal agents have been developed, but most of them fail in clinical trials due to severely adverse effects. Recently, certain natural prod...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qingmei, Liu, Kai, Shen, Qun, Li, Qingyue, Hao, Jinghui, Han, Fangxuan, Jiang, Ren-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581719/
https://www.ncbi.nlm.nih.gov/pubmed/31245292
http://dx.doi.org/10.3389/fonc.2019.00487
_version_ 1783428197549867008
author Ye, Qingmei
Liu, Kai
Shen, Qun
Li, Qingyue
Hao, Jinghui
Han, Fangxuan
Jiang, Ren-Wang
author_facet Ye, Qingmei
Liu, Kai
Shen, Qun
Li, Qingyue
Hao, Jinghui
Han, Fangxuan
Jiang, Ren-Wang
author_sort Ye, Qingmei
collection PubMed
description Multidrug resistance (MDR) resulting from different defensive mechanisms in cancer is one of the major obstacles of clinical treatment. To circumvent MDR many reversal agents have been developed, but most of them fail in clinical trials due to severely adverse effects. Recently, certain natural products have been reported to overcome MDR, including flavonoids which are abundant in plants, foods, and herbs. The structure of flavonoids can be abbreviated as C6-C3-C6 (C for carbon), and further categorized into flavonoids, iso-flavonoids and neo-flavonoids, according to their structural backbones. Flavonoids possess multiple bioactivities, and a growing body of research has indicated that both flavonoids and iso-flavonoids can either kill or re-sensitize conventional chemotherapeutics to resistant cancer cells. Here, we summarize the research and discuss the underlying mechanisms, concluding that these flavonoids do not function as specific regulators of target proteins, but rather as multi-functional agents that negatively regulate the key factors contributing to MDR.
format Online
Article
Text
id pubmed-6581719
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65817192019-06-26 Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids Ye, Qingmei Liu, Kai Shen, Qun Li, Qingyue Hao, Jinghui Han, Fangxuan Jiang, Ren-Wang Front Oncol Oncology Multidrug resistance (MDR) resulting from different defensive mechanisms in cancer is one of the major obstacles of clinical treatment. To circumvent MDR many reversal agents have been developed, but most of them fail in clinical trials due to severely adverse effects. Recently, certain natural products have been reported to overcome MDR, including flavonoids which are abundant in plants, foods, and herbs. The structure of flavonoids can be abbreviated as C6-C3-C6 (C for carbon), and further categorized into flavonoids, iso-flavonoids and neo-flavonoids, according to their structural backbones. Flavonoids possess multiple bioactivities, and a growing body of research has indicated that both flavonoids and iso-flavonoids can either kill or re-sensitize conventional chemotherapeutics to resistant cancer cells. Here, we summarize the research and discuss the underlying mechanisms, concluding that these flavonoids do not function as specific regulators of target proteins, but rather as multi-functional agents that negatively regulate the key factors contributing to MDR. Frontiers Media S.A. 2019-06-12 /pmc/articles/PMC6581719/ /pubmed/31245292 http://dx.doi.org/10.3389/fonc.2019.00487 Text en Copyright © 2019 Ye, Liu, Shen, Li, Hao, Han and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ye, Qingmei
Liu, Kai
Shen, Qun
Li, Qingyue
Hao, Jinghui
Han, Fangxuan
Jiang, Ren-Wang
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
title Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
title_full Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
title_fullStr Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
title_full_unstemmed Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
title_short Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
title_sort reversal of multidrug resistance in cancer by multi-functional flavonoids
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581719/
https://www.ncbi.nlm.nih.gov/pubmed/31245292
http://dx.doi.org/10.3389/fonc.2019.00487
work_keys_str_mv AT yeqingmei reversalofmultidrugresistanceincancerbymultifunctionalflavonoids
AT liukai reversalofmultidrugresistanceincancerbymultifunctionalflavonoids
AT shenqun reversalofmultidrugresistanceincancerbymultifunctionalflavonoids
AT liqingyue reversalofmultidrugresistanceincancerbymultifunctionalflavonoids
AT haojinghui reversalofmultidrugresistanceincancerbymultifunctionalflavonoids
AT hanfangxuan reversalofmultidrugresistanceincancerbymultifunctionalflavonoids
AT jiangrenwang reversalofmultidrugresistanceincancerbymultifunctionalflavonoids